Application of Electrically Driven Atomized Surface Anesthesia in ATI in Patients With Predictably Difficult Airway.
1 other identifier
interventional
230
1 country
1
Brief Summary
This is a parallel and randomized-controlled clinical study aimed to identify the optimized size of atomized particles of 2% lidocaine that can provide the best topical anesthesia during ATI. To determine the effect of nebulization with different sizes of atomized particles of 2% lidocaine on cough, reaction, and comfort during ATI in patients with predicted difficult airway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2024
CompletedFirst Posted
Study publicly available on registry
May 20, 2024
CompletedStudy Start
First participant enrolled
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2025
CompletedApril 22, 2025
September 1, 2024
5 months
May 12, 2024
April 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cough score
Investigators will record cough score during intubation.
during intubation
Secondary Outcomes (2)
reaction and discomfort scores
during intubation.
intraoperative hemodynamic parameters
endotracheal tube insertion, inflation of the tracheal tube cuff and 1 minute after endotracheal tube insertion
Study Arms (4)
Group A
EXPERIMENTALParticipants in the A group received 2% lidocaine by A model atomizer.
Group B
EXPERIMENTALParticipants in the B group received 2% lidocaine by B model atomizer.
Group C
EXPERIMENTALParticipants in the C group received 2% lidocaine by C model atomizer.
Group D
EXPERIMENTALParticipants in the D group received 2% lidocaine by D model atomizer.
Interventions
Participants received 2% lidocaine by atomizer.
Eligibility Criteria
You may qualify if:
- Patients with distinctly difficult airways:(1) Patients with medical history indicating difficult airways.(2) Patients suffering from severe burn scars.(3) Patients suffering from severe obstructive sleep apnea syndrome.(4)Patients suffering from severe congenital dysplasia.
- Patients with suspected difficult airway:
- Patients with risk factors underwent a medical history for evaluation:(1)Patients with ankylosing spondylitis.(2) Patients with rheumatoid arthritis.(3)Patients with degenerative osteoarthritis.(4)Patients with epiglottitis. (5)Patients with acromegaly.(6)Patients with morbid obesity.(7)Patients with subglottic stenosis. (8) Patients with enlarged thyroid or tonsils.(9)Patients with mediastinal mass.(10)Patients with throat tumors.
- Patients with risk factors underwent a physical examination for evaluation:(1)Patients with BMI \> 26 kg/m2. (2)Patients with Mallampati class 3 or 4. (3)Patients with thyromental distance\<60 mm (corresponding to an average distance of 3 finger breadths).(4)Patients with limited mouth opening with interincisor distance\<30 mm.(5)edentulous patients.(6)When the patient closed his mouth in a natural state, the upper incisor was situated in front of the lower incisor.(7)When the mandible is extended forward, the lower incisors of the patient can not protrude beyond the upper incisors.(8)The patient's jaw exhibits stiffness, with minimal elasticity or presence of a tumor.(9)The patients have a short neck with a thick circumference.(10)The patients are unable to touch their chest wall with their jaw, or extend their neck.(11)The patients's palate shape is either characterized by a high arch or is extremely narrow.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henan Provincial People's Hospital
Zhengzhou, Henan, 450003, China
Related Publications (1)
Li C, Sun M, Zhang L, Wang G, Lu J, Xie Z, Zhang J. Nebulization with differently sized 2% lidocaine atomized particles in awake tracheal intubation by video laryngoscopy: a proof-of-concept randomized trial. BMC Anesthesiol. 2025 Jul 1;25(1):321. doi: 10.1186/s12871-025-03178-9.
PMID: 40596861DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiaqiang Zhang, PHD
Henan Provincial People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2024
First Posted
May 20, 2024
Study Start
September 5, 2024
Primary Completion
January 30, 2025
Study Completion
February 5, 2025
Last Updated
April 22, 2025
Record last verified: 2024-09